Editorial: Targeting adipose tissue for the treatment of metabolic alterations

dc.contributor.author	Flori, Lorenzo
dc.contributor.author	Ramos-Molina, Bruno
dc.contributor.author	Calderone, Vincenzo
dc.contributor.author	Martelli, Alma
dc.date.accessioned	2026-04-06T11:07:38Z
dc.date.available	2026-04-06T11:07:38Z
dc.date.issued	2026-02-11
dc.identifier.citation	Flori L, Ramos-Molina B, Calderone V, Martelli A. Editorial: Targeting adipose tissue for the treatment of metabolic alterations. Front Pharmacol. 11 de febrero de 2026;17:1797423. doi:10.3389/fphar.2026.1797423
dc.identifier.uri	https://sms.carm.es/ricsmur/handle/123456789/25692
dc.language.iso	eng
dc.publisher	FRONTIERS MEDIA SA
dc.rights	Atribución/Reconocimiento 4.0 Internacional
dc.rights.uri	https://creativecommons.org/licenses/by/4.0/deed.es	*
dc.title	Editorial: Targeting adipose tissue for the treatment of metabolic alterations
dc.type	info:eu-repo/semantics/article
dc.identifier.pmid	41756232
dc.relation.publisherversion	https://www.frontiersin.org/articles/10.3389/fphar.2026.1797423/full
dc.type.version	info:eu-repo/semantics/publishedVersion
dc.identifier.doi	10.3389/fphar.2026.1797423
dc.journal.title	Frontiers in Pharmacology
dc.identifier.essn	1663-9812